IL2 and neoplasm: Once tumor volumes reached 200–300 mm3, human T cells transduced with GD2_tTF, GD2_tTFmut or CD19_tTF were intraperitoneally (i.p.)administered on days 1 and 4, along with human interleukin-2 (Fig. 4A).